Charlotte McDonagh

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD45 antibodies and conjugates thereof
- Patent number 12,209,135
- Issue date Jan 28, 2025
- VOR BIOPHARMA, INC
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD19 binding agents and uses thereof
- Patent number 11,331,394
- Issue date May 17, 2022
- SEAGEN INC.
- Charlotte McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD19 binding agents and uses thereof
- Patent number 9,919,061
- Issue date Mar 20, 2018
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CD70 binding agents and uses thereof
- Patent number 9,701,752
- Issue date Jul 11, 2017
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CD70 binding agents and uses thereof
- Patent number 9,428,585
- Issue date Aug 30, 2016
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies comprising anti-ERBB3 agents
- Patent number 9,345,766
- Issue date May 24, 2016
- Merrimack Pharmaceuticals, Inc.
- Bo Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD19 binding agents and uses thereof
- Patent number 9,073,993
- Issue date Jul 7, 2015
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human serum albumin linkers and conjugates thereof
- Patent number 8,927,694
- Issue date Jan 6, 2015
- Merrimack Pharmaceuticals, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CD70 binding agents and uses thereof
- Patent number 8,562,987
- Issue date Oct 22, 2013
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Variant target binding agents and uses thereof
- Patent number 8,455,622
- Issue date Jun 4, 2013
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 binding agents and uses thereof
- Patent number 8,257,706
- Issue date Sep 4, 2012
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD19 binding agents and uses thereof
- Patent number 8,242,252
- Issue date Aug 14, 2012
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CD70 binding agents and uses thereof
- Patent number 8,067,546
- Issue date Nov 29, 2011
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD19 binding agents and uses thereof
- Patent number 7,968,687
- Issue date Jun 28, 2011
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20240254251
- Publication date Aug 1, 2024
- VOR BIOPHARMA INC.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20240190981
- Publication date Jun 13, 2024
- Seagen Inc.
- Charlotte McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20240075157
- Publication date Mar 7, 2024
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20230135930
- Publication date May 4, 2023
- Heidelberg Pharma Research GmbH
- Charlotte Fenton McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 BINDING AGENTS AND USES THEREOF
- Publication number 20230033859
- Publication date Feb 2, 2023
- Seagen Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20220267441
- Publication date Aug 25, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20220226493
- Publication date Jul 21, 2022
- Magenta Therapeutics, Inc.
- Charlotte Fenton McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20220175944
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Charlotte F. McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
- Publication number 20220175951
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODY DRUG CONJUGATES AND USES THEREOF
- Publication number 20220177577
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Charlotte Fenton McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS)
- Publication number 20210283267
- Publication date Sep 16, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20210002380
- Publication date Jan 7, 2021
- Seattle Genetics, Inc.
- CHARLOTTE MCDONAGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20200407440
- Publication date Dec 31, 2020
- Magenta Therapeutics, Inc.
- Charlotte Fenton McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20200376135
- Publication date Dec 3, 2020
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20200255523
- Publication date Aug 13, 2020
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 BINDING AGENTS AND USES THEREOF
- Publication number 20180326087
- Publication date Nov 15, 2018
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20180066065
- Publication date Mar 8, 2018
- Merrimack Pharmaceuticals, Inc.
- Bo ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 BINDING AGENTS AND USES THEREOF
- Publication number 20180000961
- Publication date Jan 4, 2018
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20170342157
- Publication date Nov 30, 2017
- Seattle Genetics, Inc.
- CHARLOTTE MCDONAGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF
- Publication number 20170204192
- Publication date Jul 20, 2017
- Merrimack Pharmaceuticals, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20170022282
- Publication date Jan 26, 2017
- Seattle Genetics, Inc.
- Charlotte McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20160326262
- Publication date Nov 10, 2016
- Merrimack Pharmaceuticals, Inc.
- Bo ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 BINDING AGENTS AND USES THEREOF
- Publication number 20150283255
- Publication date Oct 8, 2015
- Seattle Genetics, Inc.
- Charlotte McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS
- Publication number 20150231238
- Publication date Aug 20, 2015
- Merrimack Pharmaceuticals, Inc.
- Gabriela Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20150202287
- Publication date Jul 23, 2015
- Merrimack Pharmaceuticals, Inc.
- Bo ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF
- Publication number 20150191545
- Publication date Jul 9, 2015
- Merrimack Pharmaceuticals, Inc.
- Charlotte MCDONAGH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE AND ADMINISTRATION OF BISPECIFIC SCFV CONJUGATES IN COMBINAT...
- Publication number 20150139936
- Publication date May 21, 2015
- Merrimack Pharmaceuticals, Inc.
- Sasha Frye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20140178936
- Publication date Jun 26, 2014
- Seattle Genetics, Inc.
- CHARLOTTE MCDONAGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20140079703
- Publication date Mar 20, 2014
- Merrimack Pharmaceuticals, Inc.
- Bo ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20140056898
- Publication date Feb 27, 2014
- Bo Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Charlotte McDonagh

Person

Patents Grantslast 30 patents

Anti-CD45 antibodies and conjugates thereof

CD19 binding agents and uses thereof

CD19 binding agents and uses thereof

Humanized anti-CD70 binding agents and uses thereof

Humanized anti-CD70 binding agents and uses thereof

Combination therapies comprising anti-ERBB3 agents

CD19 binding agents and uses thereof

Human serum albumin linkers and conjugates thereof

Humanized anti-CD70 binding agents and uses thereof

Variant target binding agents and uses thereof

CD30 binding agents and uses thereof

CD19 binding agents and uses thereof

Humanized anti-CD70 binding agents and uses thereof

CD19 binding agents and uses thereof

Patents Applicationslast 30 patents

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

Humanized Anti-CD70 Binding Agents and Uses Thereof

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF

CD19 BINDING AGENTS AND USES THEREOF

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF

ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

Anti-CD45 Antibody Drug Conjugates and Uses Thereof

ANTI-CD117 ANTIBODY DRUG CONJUGATES AND USES THEREOF

THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS)

Humanized Anti-CD70 Binding Agents and Uses Thereof

AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

CD19 BINDING AGENTS AND USES THEREOF

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

CD19 BINDING AGENTS AND USES THEREOF

Humanized Anti-CD70 Binding Agents and Uses Thereof

HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF

Humanized Anti-CD70 Binding Agents and Uses Thereof

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

CD19 BINDING AGENTS AND USES THEREOF

OVERCOMING RESISTANCE TO ERBB PATHWAY INHIBITORS

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF

DOSAGE AND ADMINISTRATION OF BISPECIFIC SCFV CONJUGATES IN COMBINAT...

Humanized Anti-CD70 Binding Agents and Uses Thereof

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS